JAMA Network
About The Study: The findings of this study indicate declines of more than 10 percentage points in newborn hepatitis B virus (HBV) vaccination in the last 2 years, following 6 years of growth. These estimates derived from large-scale hospital and clinic electronic health records align with WHO and CDC coverage through 2022 and provide interim surveillance for 2023-2025, a period not yet reflected in national or global reports.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
